首页 正文

Intranasal ketamine for chronic cancer-related pain in the outpatient setting: a double-edged sword

{{output}}
Introduction: Of the 11.9 million Americans living with cancer, 44% experience cancer-related pain. High-dose opioids remain the mainstay of treatment but often reduce quality-of-life (QoL) due to side effect burden, and 40% of p... ...